Viatris cordially invites you all for recorded live international exchange of experiences on Topic "Remdesivir in the management of COVID-19"
What was covered:
Module 1: Welcome Note by Dr. Ravi Shankar.
Dr Ravi Shankar introduced and welcomed both the speakers and their topics for the evening.
Module 2: Remdesivir in the management of COVID-19 by Dr. Barry S. Zingman.
Update on Remdisivir use in COVID-19 discussed
-COVID-19 description – Distribution of the disease worldwide. Pathophysiology of the disease and non-pharmacological preventive measures explained. Symptoms of COVID-19 and diagnostic methods explained stagewise. Management of the disease discussed with respect to stage and complications. Therauptic approaches with respect to antivirals and immunomodulators discussed according to stage.
-Specific therapies for COVID-19
-Remdesivir pivotal studies discussion:
-The drug pharmacology and studies involving use of Remdesivir discussed.
-Who solidarity trail discussed in detail
-US FDA approval for Remdesivir: Safety information and warnings
-Status elsewhere
-Guidelines recommended
-Questions were addressed post presentation
Module 3: Remdesivir for Managing Severe COVID-19 in India – Real World Evidence by Dr. Ravindra Mehta.
-The study conducted at hospital on use of Remdesivir was discussed with respect to:
-Aim of the study conducted: The real-world stimulus to look further in the midst of emerging information (or confusion)
-Objective and study design of the study explained
-Methodology of the study discussed
-Baseline characteristics of the whole group
-Results explained
-Analysis and interpretation of use of Remdesivir discussed
-Conclusions and limitations of the study explained
-COVID-19 treatment modalities discussed stage wise and different presentations with respect to pathophysiology and treatment options
-The hindrances and challenges to early treatment in COVID-19 discussed
-Questions were addressed post presentation
We thank our sponsors Viatris to make this program possible. Wish you a great learning experience.
